Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noman Paracha

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
JCO Precision Oncology|September 19, 2025
Clinical Benefit From Molecularly Guided Cancer Care: A Matching-Adjusted Indirect Comparison of Larotrectinib Versus Standard of CareCarsten Bokemeyer, Keith R Abrams, Jesus Garcia-Foncillas, et al.
Clinical Drug Investigation|October 25, 2011
Reduction in healthcare and societal resource utilization associated with cladribine tablets in patients with relapsing-remitting multiple sclerosis: analysis of economic data from the CLARITY StudyShehzad Ali, Noman Paracha, Stuart Cook, et al.
Prostate Cancer and Prostatic Diseases|December 9, 2025
Efficacy and safety of treatments for metastatic castration-sensitive prostate cancer: A comprehensive network meta-analysis including final ARANOTE dataNeal Shore, Alicia K Morgans, Noman Paracha, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
JCO Precision Oncology|September 19, 2025
Clinical Benefit From Molecularly Guided Cancer Care: A Matching-Adjusted Indirect Comparison of Larotrectinib Versus Standard of CareCarsten Bokemeyer, Keith R Abrams, Jesus Garcia-Foncillas, et al.
Clinical Drug Investigation|October 25, 2011
Reduction in healthcare and societal resource utilization associated with cladribine tablets in patients with relapsing-remitting multiple sclerosis: analysis of economic data from the CLARITY StudyShehzad Ali, Noman Paracha, Stuart Cook, et al.
Prostate Cancer and Prostatic Diseases|December 9, 2025
Efficacy and safety of treatments for metastatic castration-sensitive prostate cancer: A comprehensive network meta-analysis including final ARANOTE dataNeal Shore, Alicia K Morgans, Noman Paracha, et al.
Pageof 4